Oral regimen ‘delays onset of MS’
Oral regimen ‘delays onset of MS’
For the first time, an oral therapy has been proven to reduce the risk of developing clinically definite multiple sclerosis in patients with a clinically isolated syndrome. In a phase III trial published in the journal Lancet Neurology, Miller et al clarified the role of teriflunomide (Aubagio) in the treatment of early episodes of demyelinating symptoms suggestive of MS...... Read More - http://www.ms-uk.org/aubagio
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 837 Views
-
Last post by NHE
-
- 0 Replies
- 1123 Views
-
Last post by NHE
-
- 0 Replies
- 2467 Views
-
Last post by frodo
-
- 1 Replies
- 1121 Views
-
Last post by jimmylegs
-
- 0 Replies
- 1667 Views
-
Last post by NHE
-
- 0 Replies
- 1412 Views
-
Last post by frodo
-
- 0 Replies
- 2201 Views
-
Last post by vesta
-
- 1 Replies
- 1146 Views
-
Last post by Petr75
-
- 0 Replies
- 162 Views
-
Last post by NHE